We are live on ! Find out more
SCM

SKBA Capital Management Portfolio holdings

AUM $728M
1-Year Est. Return 12.18%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+12.18%
3 Year Est. Return
+52.29%
5 Year Est. Return
+76.86%
10 Year Est. Return
+235.51%
AUM
$594M
AUM Growth
+$51.9M
Cap. Flow
-$572K
Cap. Flow %
-0.1%
Top 10 Hldgs %
30.45%
Holding
82
New
6
Increased
17
Reduced
44
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$8.91M
2
KVUE icon
Kenvue
KVUE
+$7.91M
3
HAS icon
Hasbro
HAS
+$5.48M
4
LHX icon
L3Harris
LHX
+$5.22M
5
PNW icon
Pinnacle West Capital
PNW
+$3.22M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.34M
2
NTR icon
Nutrien
NTR
+$5.27M
3
AZN icon
AstraZeneca
AZN
+$4.98M
4
OGE icon
OGE Energy
OGE
+$4.79M
5
GLW icon
Corning
GLW
+$4.63M

Sector Composition

Rank Sector Weight
1 Financials 18.35%
2 Healthcare 13.46%
3 Consumer Discretionary 12.76%
4 Technology 11.08%
5 Industrials 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
1
ConocoPhillips
COP
$147B
$21.1M 3.55%
181,725
-2,050
-1% -$240K
RTX icon
2
RTX Corp
RTX
$290B
$20.3M 3.43%
241,832
+38,685
+19% +$3.06M
KTB icon
3
Kontoor Brands
KTB
$4.63B
$19.7M 3.31%
315,154
-25,960
-8% -$1.33M
MRK icon
4
Merck
MRK
$322B
$19.4M 3.26%
177,635
+12,300
+7% +$1.28M
PHG icon
5
Philips
PHG
$25.7B
$18.2M 3.06%
869,833
-9,391
-1% -$171K
IBM icon
6
IBM
IBM
$211B
$17.5M 2.95%
107,250
-16,650
-13% -$2.52M
DRI icon
7
Darden Restaurants
DRI
$23.3B
$17M 2.86%
103,370
-540
-0.5% -$81.8K
T icon
8
AT&T
T
$159B
$16.3M 2.75%
971,650
+8,500
+0.9% +$134K
NXPI icon
9
NXP Semiconductors
NXPI
$57.8B
$16M 2.69%
69,595
-400
-0.6% -$80.5K
CME icon
10
CME Group
CME
$96.3B
$15.4M 2.59%
73,010
+220
+0.3% +$46.9K
CRBG icon
11
Corebridge Financial
CRBG
$14.1B
$14.8M 2.49%
683,690
+34,600
+5% +$714K
INGR icon
12
Ingredion
INGR
$6.27B
$14.7M 2.48%
135,725
-600
-0.4% -$60.2K
MDT icon
13
Medtronic
MDT
$109B
$14.5M 2.44%
175,529
+38,395
+28% +$2.93M
KMI icon
14
Kinder Morgan
KMI
$71.7B
$13.9M 2.35%
790,320
+167,200
+27% +$2.85M
CMCSA icon
15
Comcast
CMCSA
$85B
$13.2M 2.22%
300,066
-600
-0.2% -$25.7K
AIG icon
16
American International
AIG
$41.7B
$12.6M 2.13%
186,685
-2,300
-1% -$147K
MET icon
17
MetLife
MET
$61.9B
$12.3M 2.07%
185,900
-2,500
-1% -$156K
NTAP icon
18
NetApp
NTAP
$35B
$12.3M 2.07%
139,250
-13,600
-9% -$1.09M
PSX icon
19
Phillips 66
PSX
$84.9B
$12.1M 2.04%
90,935
-12,600
-12% -$1.51M
RDN icon
20
Radian Group
RDN
$5.18B
$11.6M 1.95%
406,100
-2,500
-0.6% -$65.9K
WFC icon
21
Wells Fargo
WFC
$261B
$11M 1.85%
223,150
-3,200
-1% -$138K
SCHW
22
Charles Schwab
SCHW
$183B
$10.9M 1.84%
158,960
-2,200
-1% -$127K
LEA icon
23
Lear
LEA
$6.54B
$10.9M 1.83%
76,990
+2,700
+4% +$362K
CAH icon
24
Cardinal Health
CAH
$53.9B
$10.9M 1.83%
107,850
-25,800
-19% -$2.56M
PNW icon
25
Pinnacle West Capital
PNW
$12.2B
$10.8M 1.82%
150,250
+43,850
+41% +$3.22M

Similar funds

SKBA Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, SKBA Capital Management held 82 positions worth $594M, up 9.6% from $542M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

SKBA Capital Management's Q4 2023 filing shows 6 new, 17 increased, 44 reduced and 6 closed positions. Its largest new stake was Pfizer: 294,600 shares worth $8.48M. The largest sale was Amgen, an estimated $5.34M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • SKBA Capital Management's largest Q4 2023 buy was Pfizer: 294,600 shares worth $8.48M.
  • SKBA Capital Management added most to Pinnacle West Capital in Q4 2023, an estimated $3.22M increase.
  • SKBA Capital Management's biggest Q4 2023 reduction was Amgen, cutting an estimated $5.34M.
  • SKBA Capital Management fully exited Nutrien in Q4 2023, selling an estimated $5.27M.
  • SKBA Capital Management's ten largest holdings make up 30% of its $594M portfolio in Q4 2023.
  • SKBA Capital Management opened 6 new positions and closed 6 in Q4 2023.
  • SKBA Capital Management's portfolio value rose 9.6% quarter-over-quarter to $594M.

Based on SKBA Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.